Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors [Yahoo! Finance]
Calidi Biotherapeutics, Inc. (CLDI)
Company Research
Source: Yahoo! Finance
a systemic administration -- a long-pursued breakthrough by the biopharma industry. RTNova utilizes a potent vaccinia virus enveloped by a human cell membrane, designed to evade human immunity and enhance its therapeutic functions. RTNova's novel therapeutic approach allows for ease of administration and the ability to reach a broad patient population. SIGA will supply TPOXX ® (Tecovirimat), an effective antiviral agent against vaccinia virus, to support the development of RTNova and accelerate development of extracellular enveloped vaccinia virus-based anticancer therapies. SAN DIEGO, June 10, 2024 BUSINESS WIRE )--Calidi Biotherapeutics, Inc. (NYSE American: CLDI or "Calidi"), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that it entered into a collaboration agreement with SIGA Technologies (Nasdaq: SIGA) in the first quarter of 2024, to support the development of Calidi's systemic and targeted RTNova
Show less
Read more
Impact Snapshot
Event Time:
CLDI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLDI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLDI alerts
High impacting Calidi Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CLDI
News
- Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results [Yahoo! Finance]Yahoo! Finance
- Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial ResultsGlobeNewswire
- Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald RigorGlobeNewswire
- Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology PlatformGlobeNewswire
- Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board [Yahoo! Finance]Yahoo! Finance
CLDI
Sec Filings
- 9/24/24 - Form 8-K
- 9/12/24 - Form 8-K
- 9/11/24 - Form SC
- CLDI's page on the SEC website